OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Pulmonary Medicine is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Chronic obstructive pulmonary disease and COVID-19: interrelationships	56
Pulmonary pathology of COVID-19: a review of autopsy studies	47
A clinical review of long-COVID with a focus on the respiratory system	35
Drug-induced sarcoidosis-like reactions	29
COVID-19: vaccines, efficacy and effects on variants	26
Drug treatment of COVID-19 infection	24
New guidelines for severe community-acquired pneumonia	23
Genetics in sarcoidosis	22
The role of computed tomography scan in the diagnosis of COVID-19 pneumonia	21
Risk stratification of indeterminate pulmonary nodules	20
Pulmonary hypertension in interstitial lung disease: screening, diagnosis and treatment	20
Pleuroparenchymal fibroelastosis	20
Telehealth and virtual health monitoring in cystic fibrosis	18
The other connective tissue disease-associated interstitial lung diseases: Sjogren's syndrome, mixed connective tissue disease, and systemic lupus erythematosus	18
Impact of obesity on pulmonary function: current understanding and knowledge gaps	17
COVID-19 and other respiratory tract infections at mass gathering religious and sporting events	17
Triple combination cystic fibrosis transmembrane conductance regulator modulator therapy in the real world – opportunities and challenges	17
The impact of fungal allergic sensitization on asthma	17
Sarcoidosis and autoimmunity	16
Implementation of digital home monitoring and management of respiratory disease	16
COVID-19 outcomes in people with cystic fibrosis	16
Upper airway muscles: influence on obstructive sleep apnoea pathophysiology and pharmacological and technical treatment options	16
COVID-19: a new burden of respiratory disease among South African miners?	15
ICU preparedness in pandemics: lessons learned from the coronavirus disease-2019 outbreak	15
Drug-resistant tuberculosis: advances in diagnosis and management	15

Pulmonary rehabilitation in a postcoronavirus disease 2019 world: feasibility, challenges, and solutions	14
Update on sarcoidosis guidelines	14
Severe pulmonary toxicity associated with inhalation of pyrethroid-based domestic insecticides (Bop/Sapolio): a case series and literature review	14
Nontuberculous mycobacteria in cystic fibrosis	14
Neuropsychiatric adverse effects from CFTR modulators deserve a serious research effort	14
Obstructive lung diseases and allergic bronchopulmonary aspergillosis	13
The role of PET in the management of sarcoidosis	13
Robotic bronchoscopy and future directions of interventional pulmonology	13
Advances in the epidemiology, clinical features, diagnosis, clinical management and prevention of coronavirus disease 2019	13
Airborne transmission of respiratory viruses including severe acute respiratory syndrome coronavirus 2	12
The current understanding and future directions for sputum microbiome profiling in chronic obstructive pulmonary disease	12
COVID-19 new diagnostics development: novel detection methods for SARS-CoV-2 infection and considerations for their translation to routine use	12
Epidemiology and real-life experience in progressive pulmonary fibrosis	12
Rapid eye movement predominant obstructive sleep apnoea: prognostic relevance and clinical approach	11
Telehealth in chronic obstructive pulmonary disease: before, during, and after the coronavirus disease 2019 pandemic	11
Hit-hard and early versus step-up treatment in severe sarcoidosis	11
SMART - is it practical in the United States?	11
Vaping epidemic in US teens: problem and solutions	11
Robotic bronchoscopy for peripheral pulmonary lesions: a convergence of technologies	11
Advancing bacteriophages as a treatment of antibiotic-resistant bacterial pulmonary infections	11
Lung microbiome, gut–lung axis and chronic obstructive pulmonary disease	11
Beta-blockers in chronic obstructive pulmonary disease: the good, the bad and the ugly	10
Current practices in the management of central airway obstruction	10
Pulmonary adverse events following immune checkpoint inhibitors	10
Influenza: clinical aspects, diagnosis, and treatment	10
Unprecedented: the toxic synergism of Covid-19 and climate change	10
Pulmonary toxicity associated with occupational and environmental exposure to pesticides and herbicides	10
The evolving role of radiological imaging in cystic fibrosis	10
Chronic obstructive pulmonary disease risk assessment tools: is one better than the others?	10
Atypical mycobacterial infections – management and when to treat	10
Drug-induced comorbidities in patients with sarcoidosis	9
Biopsy in interstitial lung disease: specific diagnosis and the identification of the progressive fibrotic phenotype	9
Glymphatic MRI techniques in sleep and neurodegenerative diseases	9
The justification for the progressive fibrotic phenotype	9
Sarcoidosis associated pulmonary hypertension: an update	9
Lethal zoonotic coronavirus infections of humans – comparative phylogenetics, epidemiology, transmission, and clinical features of coronavirus disease 2019, The Middle East respiratory syndrome and se	9
At a crossroads: coronavirus disease 2019 recovery and the risk of pulmonary vascular disease	9
Sleep medicine and coronavirus disease 2019	8
Bronchoscopic diagnosis of peripheral lung lesions	8
COVID-19 – pathogenesis and immunological findings across the clinical manifestation spectrum	8
COVID-19 infection in patients with sarcoidosis: susceptibility and clinical outcomes	8
Emerging clinical perspectives in cystic fibrosis liver disease	8
Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: advances in patient and lesion selection	8
Asthma guidelines: comparison of the National Heart, Lung, and Blood Institute Expert Panel Report 4 with Global Initiative for Asthma 2021	8
Telerehabilitation in pulmonary diseases	8
New pharmacologic agents for obstructive sleep apnoea: what do we know and what can we expect?	7
Recent advances in the management of systemic sclerosis-associated interstitial lung disease	7
Revealing the pathogenic and ageing-related mechanisms of the enigmatic idiopathic pulmonary fibrosis (and chronic obstructive pulmonary disease)	7
Obstructive lung diseases burden and COVID-19 in developing countries: a perspective	7
Military deployment-related respiratory problems: an update	7

Interstitial lung disease in patients with anti-neutrophil cytoplasm antibody-associated vasculitis: an update on pathogenesis and treatment	7
Respiratory viral infections in the immunocompromised	7
Home monitoring in asthma: towards digital twins	7
The progressive fibrotic phenotype in current clinical practice	7
Occupational exposures and sarcoidosis: current understanding and knowledge gaps	7
Sarcoidosis and maligancy: the chicken and the egg?	7
Therapeutic pipeline for individuals with cystic fibrosis with mutations nonresponsive to current cystic fibrosis transmembrane conductance regulator modulators	6
Unclassifiable, or simply unclassified interstitial lung disease?	6
Lung cancer staging, the established role of bronchoscopy	6
Environmental and occupational exposures in interstitial lung disease	6
Transbronchial lung cryobiopsy for the diagnosis of interstitial lung diseases	6
Care of the postcoronavirus disease 2019 patient	6
Malignant pleural disease: a pragmatic guide to diagnosis	6
Personalized medicine in sarcoidosis: unravelling biomarkers for targeted care	6
Management of patients with idiopathic pulmonary fibrosis and lung cancer: challenges in clinical practice	6
Advances in development of new tuberculosis vaccines	6
Silica-associated lung disease in developing countries	6
Management of pneumothorax: an update	6
Therapeutic bronchoscopy for malignant central airway obstruction: impact on quality of life and risk-benefit analysis	6
Progress and challenges in fungal lung disease in cystic fibrosis	6
More than sleepiness: prevalence and relevance of nonclassical symptoms of obstructive sleep apnea	6
Percutaneous tracheostomy in the ICU: a review of the literature and recent updates	6
Sleep in the intensive care unit	6
The different facets of sickle cell disease-related pulmonary hypertension	6
Cyclic alternating patterns and arousals: what is relevant in obstructive sleep apnea? In Memoriam Mario Giovanni Terzano	6